113 related articles for article (PubMed ID: 8596564)
1. Drug-induced hepatotoxicity.
Noble A; MacDonald A
N Engl J Med; 1996 Mar; 334(13):864. PubMed ID: 8596564
[No Abstract] [Full Text] [Related]
2. Severe dapsone syndrome due to weekly maloprim.
Grayson ML; Yung AP; Doherty RR
Lancet; 1988 Mar; 1(8584):531. PubMed ID: 2893942
[No Abstract] [Full Text] [Related]
3. Fixed drug eruptions to maloprim.
Tham SN; Chan HL
Singapore Med J; 1988 Jun; 29(3):300-2. PubMed ID: 2973126
[No Abstract] [Full Text] [Related]
4. "Black spots" in Papua New Guinea Defence Force personnel: report of 12 cases.
Talwat EN
Australas J Dermatol; 1983 Aug; 24(2):69-70. PubMed ID: 6229242
[No Abstract] [Full Text] [Related]
5. Serious adverse drug reactions to pyrimethamine-sulphadoxine, pyrimethamine-dapsone and to amodiaquine in Britain.
Phillips-Howard PA; West LJ
J R Soc Med; 1990 Feb; 83(2):82-5. PubMed ID: 2138674
[TBL] [Abstract][Full Text] [Related]
6. Dapsone hypersensitivity syndrome masquerading as a viral exanthem: three cases and a mini-review.
Tee AK; Oh HM; Wee IY; Khoo BP; Poh WT
Ann Acad Med Singap; 2004 May; 33(3):375-8. PubMed ID: 15175785
[TBL] [Abstract][Full Text] [Related]
7. Dapsone hypersensitivity. The sulfone syndrome revisited.
Tomecki KJ; Catalano CJ
Arch Dermatol; 1981 Jan; 117(1):38-9. PubMed ID: 6450569
[TBL] [Abstract][Full Text] [Related]
8. Dapsone syndrome.
Ramanan C; Ghorpade A; Manglani PR
Indian J Lepr; 1991; 63(2):226-8. PubMed ID: 1838381
[No Abstract] [Full Text] [Related]
9. Agranulocytosis during malaria prophylaxis with Maloprim (pyrimethamine and dapsone).
Booth F; Barker LC; Barton CJ; Naik RB
Postgrad Med J; 1984 Aug; 60(706):566-7. PubMed ID: 6473241
[TBL] [Abstract][Full Text] [Related]
10. Chemoprophylaxis of malaria in Africa.
Rée GH
Br Med J (Clin Res Ed); 1983 Feb; 286(6364):562. PubMed ID: 6402151
[No Abstract] [Full Text] [Related]
11. Adverse reactions to Fansidar.
Kollisch DO
J Fam Pract; 1986 Sep; 23(3):202-4. PubMed ID: 2943869
[No Abstract] [Full Text] [Related]
12. Maloprim and agranulocytosis.
Bruce-Chwatt LJ; Hutchinson DB
Lancet; 1983 Dec 24-31; 2(8365-66):1487-8. PubMed ID: 6140569
[No Abstract] [Full Text] [Related]
13. Agranulocytosis associated with Maloprim.
Bruce-Chwatt LJ; Hutchinson DB
Br Med J (Clin Res Ed); 1984 Jan; 288(6410):65-6. PubMed ID: 6418319
[No Abstract] [Full Text] [Related]
14. Maloprim-induced pulmonary eosinophilia.
Begbie S; Burgess KR
Chest; 1993 Jan; 103(1):305-6. PubMed ID: 8417912
[TBL] [Abstract][Full Text] [Related]
15. Hypersensitivity syndrome associated with dapsone/pyrimethamine (Maloprim) antimalaria chemoprophylaxis.
Thong BY; Leong KP; Chng HH
Ann Allergy Asthma Immunol; 2002 May; 88(5):527-9. PubMed ID: 12027077
[TBL] [Abstract][Full Text] [Related]
16. Maloprim for malaria prophylaxis.
Donovan KD
Med J Aust; 1985 Sep; 143(7):319-20. PubMed ID: 4046929
[No Abstract] [Full Text] [Related]
17. Idiosyncratic reaction resembling toxic epidermal necrolysis caused by chloroquine and maloprim.
Phillips-Howard PA; Warwick Buckler J
Br Med J (Clin Res Ed); 1988 Jun; 296(6636):1605. PubMed ID: 3135033
[No Abstract] [Full Text] [Related]
18. [Pruritus, exanthema, icterus and fever].
Groth H; Rhyner K; Vetter W
Schweiz Rundsch Med Prax; 1987 May; 76(20):570-4. PubMed ID: 3629058
[No Abstract] [Full Text] [Related]
19. Pulmonary toxicity of malaria prophylaxis.
Davidson AC; Bateman C; Shovlin C; Marrinan M; Burton GH; Cameron IR
BMJ; 1988 Nov; 297(6658):1240-1. PubMed ID: 3145065
[No Abstract] [Full Text] [Related]
20. [A case of hypersensitivity type of liver injury induced by pyrimetamine and sulfadoxin (Fansidar)].
Okazaki Y; Watanabe N; Uchiyama J; Nakano A; Nishizaki Y; Kagawa T; Matsuzaki S
Nihon Shokakibyo Gakkai Zasshi; 1997 Feb; 94(2):129-32. PubMed ID: 9071177
[No Abstract] [Full Text] [Related]
[Next] [New Search]
